| Psoriasis |
1 |
1 |
| Suicide |
0 |
0.93 |
| Depression |
0 |
0.86 |
| Biologic Therapy |
0 |
0.66 |
| Clinical Research |
0 |
0.17 |
| Healthcare and Medical Technology |
0 |
0.15 |
| Anxiety |
0 |
0.12 |
| California |
0 |
0.12 |
| Washington |
0 |
0.12 |
| Risk Evaluation and Mitigation Strategies |
0 |
0.1 |
| Anxiety Disorder |
0 |
0.08 |
| Patient Safety |
0 |
0.07 |
| Revenue and Practice Management |
0 |
0.07 |
| Board Certification |
0 |
0.06 |
| Cancer |
0 |
0.06 |
| Cytokines |
0 |
0.06 |
| Depression History |
0 |
0.06 |
| Geriatrics |
0 |
0.06 |
| Interleukin |
0 |
0.06 |
| Isolation |
0 |
0.06 |
| Mental Illness |
0 |
0.06 |
| Meta-Analysis |
0 |
0.06 |
| Monoclonal Antibody |
0 |
0.06 |
| Plaque Psoriasis |
0 |
0.06 |
| Primary Care |
0 |
0.06 |
| Prisons |
0 |
0.06 |
| Receptors |
0 |
0.06 |
| Students |
0 |
0.06 |
| Teledermatology |
0 |
0.06 |